☰

Douglas L. Sheridan, Ph.D. - Publications

Affiliations: 
Interdepartmental neuroscience program Yale University, New Haven, CT 
Area:
molecular neuroscience
Tree Info Grants Similar researchers PubMed Report error

4/14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Sheridan D, Yu ZX, Zhang Y, Patel R, Sun F, Lasaro MA, Bouchard K, Andrien B, Marozsan A, Wang Y, Tamburini P. Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action. Plos One. 13: e0195909. PMID 29649283 DOI: 10.1371/Journal.Pone.0195909  0.318
2006 Sheridan DL, Robert A, Cho CH, Howe JR, Hughes TE. Regions of alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid receptor subunits that are permissive for the insertion of green fluorescent protein. Neuroscience. 141: 837-49. PMID 16765522 DOI: 10.1016/J.Neuroscience.2006.04.052  0.522
2004 Sheridan DL, Hughes TE. A faster way to make GFP-based biosensors: two new transposons for creating multicolored libraries of fluorescent fusion proteins. Bmc Biotechnology. 4: 17. PMID 15317651 DOI: 10.1186/1472-6750-4-17  0.526
2002 Sheridan DL, Berlot CH, Robert A, Inglis FM, Jakobsdottir KB, Howe JR, Hughes TE. A new way to rapidly create functional, fluorescent fusion proteins: random insertion of GFP with an in vitro transposition reaction. Bmc Neuroscience. 3: 7. PMID 12086589 DOI: 10.1186/1471-2202-3-7  0.539
Low-probability matches (unlikely to be authored by this person)
2008 Sheridan DL, Kong Y, Parker SA, Dalby KN, Turk BE. Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs. The Journal of Biological Chemistry. 283: 19511-20. PMID 18482985 DOI: 10.1074/Jbc.M801074200  0.295
2016 Schatz-Jakobsen JA, Zhang Y, Johnson K, Neill A, Sheridan D, Andersen GR. Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway. Journal of Immunology (Baltimore, Md. : 1950). PMID 27194791 DOI: 10.4049/Jimmunol.1600280  0.293
2010 Mok J, Kim PM, Lam HY, Piccirillo S, Zhou X, Jeschke GR, Sheridan DL, Parker SA, Desai V, Jwa M, Cameroni E, Niu H, Good M, Remenyi A, Ma JL, et al. Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Science Signaling. 3: ra12. PMID 20159853 DOI: 10.1126/Scisignal.2000482  0.268
2005 Tierney J, Sheridan D, Mascavage L, Gorbecheva D, Ripp M, Son S. A Preliminary Study On Predicting The 13C Chemical Shifts For A Series Of Disubstituted 2,3-Diphenyl-1,3-Thiazolidin-4-Ones Heterocyclic Communications. 11: 215-222. DOI: 10.1515/Hc.2005.11.3-4.215  0.253
2016 Sheridan D, Yu Z, Zhang Y, Patel R, Lasaro M, Bouchard K, Andrien B, Marozsan A, Wang Y, Tamburini P. Design and preclinical characterization of ALXN1210: A next generation anti-C5 monoclonal antibody with improved pharmacokinetics and duration of action Immunobiology. 221: 1158. DOI: 10.1016/J.Imbio.2016.06.078  0.248
2015 Sahelijo L, Mujeebuddin A, Mitchell D, Larouche R, Yu Z, Zhang Y, Patel R, Lasaro M, Bouchard K, Andrien B, Wang Y, Tamburini P, Macdonald S, Sheridan D, Soni P. First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals Blood. 126: 4777-4777. DOI: 10.1182/Blood.V126.23.4777.4777  0.246
2000 Tieraev J, Sheridan D, Kovalesky K. Substituent Effects For Some Substituted 3-Benzyl-2-Phenyl-1.3- Thiazolid In-4-On Es Using 1H And 13C Nmr Heterocyclic Communications. 6: 105-112. DOI: 10.1515/Hc.2000.6.2.105  0.231
2004 Numis AL, Unger EL, Sheridan DL, Chisnell AC, Andrews AM. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP). Molecular Pharmacology. 66: 718-27. PMID 15322265 DOI: 10.1124/Mol.66.3  0.214
2014 Kahk JM, Sheridan DL, Kehoe AB, Scanlon DO, Morgan BJ, Watson GW, Payne DJ. The electronic structure of silver orthophosphate: Experiment and theory Journal of Materials Chemistry A. 2: 6092-6099. DOI: 10.1039/C3Ta14191H  0.041
1993 Norville HS, Bove PM, Sheridan DL, Lawrence SL. Strength of new heat treated window glass Lites and laminated glass units Journal of Structural Engineering (United States). 119: 891-901. DOI: 10.1061/(ASCE)0733-9445(1993)119:3(891)  0.011
Hide low-probability matches.